Cortisone-reductase deficiency associated with heterozygous mutations in 11β-hydroxysteroid dehydrogenase type 1
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
In peripheral target tissues, levels of active glucocorticoid hormones are controlled by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), a dimeric enzyme that catalyzes the reduction of cortisone to cortisol within the endoplasmic reticulum. Loss of this activity results in a disorder termed cortisone reductase deficiency (CRD), typified by increased cortisol clearance and androgen excess. To date, only mutations in H6PD , which encodes an enzyme supplying cofactor for the reaction, have been identified as the cause of disease. Here we examined the HSD11B1 gene in two cases presenting with biochemical features indicative of a milder form of CRD in whom the H6PD gene was normal. Novel heterozygous mutations (R137C or K187N) were found in the coding sequence of HSD11B1 . The R137C mutation disrupts salt bridges at the subunit interface of the 11β-HSD1 dimer, whereas K187N affects a key active site residue. On expression of the mutants in bacterial and mammalian cells, activity was either abolished (K187N) or greatly reduced (R137C). Expression of either mutant in a bacterial system greatly reduced the yield of soluble protein, suggesting that both mutations interfere with subunit folding or dimer assembly. Simultaneous expression of mutant and WT 11β-HSD1 in bacterial or mammalian cells, to simulate the heterozygous condition, indicated a marked suppressive effect of the mutants on both the yield and activity of 11β-HSD1 dimers. Thus, these heterozygous mutations in the HSD11B1 gene have a dominant negative effect on the formation of functional dimers and explain the genetic cause of CRD in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Affected patients may present with premature adrenarche in childhood including pubarche, or as adolescents and adults with androgen excess and a PCOS-like phenotype in females (4, 5, 10) .”
From Novel H6PDH mutations in two girls with premature adrenarche: ‘apparent’ and ‘true’ CRD can be differentiated by urinary steroid profiling (2013) · cites this paper as [5]
In the citing paper
“Cortisone reductase deficiency (CRD) and apparent CRD (ACRD) are characterised by the failure to generate cortisol from inactive cortisone resulting in HPA axis activation and excessive ACTH-mediated adrenal androgen secretion, with ∼14 cases described clinically and biochemically in the literature (1, 2, 3, 4, 5, 6, 7, 8, 9) .”
From Novel H6PDH mutations in two girls with premature adrenarche: ‘apparent’ and ‘true’ CRD can be differentiated by urinary steroid profiling (2013) · cites this paper as [5]
In the citing paper
“Mutations in HSD11B1 explain CRD that leads to loss of cortisol regeneration and increased cortisol clearance with secondary activation of the HPA axis (5, 11) .”
From Novel H6PDH mutations in two girls with premature adrenarche: ‘apparent’ and ‘true’ CRD can be differentiated by urinary steroid profiling (2013) · cites this paper as [5]
In the citing paper
“CRD is caused by HSD11B1 deficiency (90) whereas ACRD results form a deficiency in the activity of H6PDH, which is essential for maintaining the reductive activity of HSD11B1 in vivo by the reduced form of NAD phosphate provision to the enzyme (91, 92).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [90]
In the citing paper
“Urine steroid profiling reveals distinct alterations in glucocorticoid metabolism accompanied by an overall increase of androgen excretion rates (90, 92, 95).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [90]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828 · cited 1×
“Structural images were produced using UCSF Chimera from the University of California San Francisco’s Resource for Biocomputing, Visualization, and Informatics (supported by National Institutes of Health Grant P41 RR-01081) (36).”
MethodBig Effects from Small Changes: Possible Ways to Explore Nature's Chemical Diversity
Bode, H. B., Bethe, B., Höfs, R., & Zeeck, A. (2002) · ChemBioChem · doi:10.1002/1439-7633(20020703)3:7<619::aid-cbic619>3.0.co;2-9 · Cited by 1,237
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
Self-citationKotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753
Self-citationCritical Residues for Structure and Catalysis in Short-chain Dehydrogenases/Reductases
Filling, C., Berndt, K. D., Benach, J., Knapp, S., Prozorovski, T., Nordling, E., Ladenstein, R., Jörnvall, H., & Oppermann, U. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202160200 · Cited by 583 · cited 1×
“core catalytic tetrad of Asn, Ser, Tyr, and Lys required for enzyme activity (24).”
BackgroundClose-Range Electrostatic Interactions in Proteins
Kumar, S., & Nussinov, R. (2002) · ChemBioChem · doi:10.1002/1439-7633(20020703)3:7<604::aid-cbic604>3.0.co;2-x · Cited by 545
Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
ESTEBAN, N. V., LOUGHLIN, T., YERGEY, A. L., ZAWADZKI, J. K., BOOTH, J. D., WINTERER, J. C., & LORIAUX, D. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-39 · Cited by 481 · cited 2×
“This type of effect has been reported for the enzyme biotin carboxylase, where an inactivating mutation in the active site of one monomer of the protein was found to have a dominant negative effect on the other monomer, resulting in a 285-fold decrease in activity (21).”
BackgroundMethodProtein Stability and Surface Electrostatics: A Charged Relationship
Strickler, S. S., Gribenko, A. V., Gribenko, A. V., Keiffer, T. R., Tomlinson, J., Reihle, T., Loladze, V. V., & Makhatadze, G. I. (2006) · Biochemistry · doi:10.1021/bi0600143 · Cited by 333
Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research
Shackleton, C. H. L. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90132-g · Cited by 247 · cited 1×
“Adrenal-derived urinary steroid metabolites were measured on complete 24-h collections by GC/MS-selected ion monitoring, as reported previously (17,34).”
Method
Research works printed but not linked: 2
- NF Taylor, WA Bartlett, DJ Dawson, Cortisone reductase deficiency: Evidence for a new inborn error in metabolism of adrenal steroids. J Endocrinol 102S, 1 (1984).
- MW Savage, Increased metabolic clearance of cortisol in corticosteroid 11-reductase deficiency. J Endocrinol 129S, 1 (1991).
Cited by
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
“Lower 11 -HSD1 activity has been advocated based on the prominent hyperandrogenism seen in apparent cortisone reductase (H6PDH) deficiency (390) and cortisone reductase (HSD11B1) deficiency (393).”
BackgroundInfluentialMartin, K. A., Chang, R. J., Ehrmann, D. A., Ibanez, L., Lobo, R. A., Rosenfield, R. L., Shapiro, J., Montori, V. M., & Swiglo, B. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2437 · Cited by 512
Martin, K. A., Anderson, R. R., Chang, R. J., Ehrmann, D. A., Lobo, R. A., Murad, M. H., Pugeat, M. M., & Rosenfield, R. L. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00241 · Cited by 339
“Further workup to identify the origin of androgen excess may be clinically indicated because of atypical clinical or laboratory findings and may include the following: (1) measuring serum androstenedione (the immediate precursor for testosterone) (28) or other steroid intermediates [that have on occasion provided addi…”
BackgroundTreating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?
Pofi, R., Caratti, G., Ray, D. W., & Tomlinson, J. W. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad016 · Cited by 209
“…mutations in the gene encoding 11 β -HSD1 (HSD11B1), or its accessory enzyme hexose-6-phosphate dehydrogenase (H6PDH) that generates its cosubstrate (NADPH) to permit reductase activity (25), develop cortisone reductase deficiency and apparent cortisone reductase deficiency, respectively (494-498).”
Background11β-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects
Gathercole, L. L., Lavery, G. G., Morgan, S. A., Cooper, M. S., Sinclair, A. J., Tomlinson, J. W., & Stewart, P. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1050 · Cited by 196
Self-citation
Metadata
- Authors
- Lawson, A. J., Walker, E. A., Lavery, G. G., Bujalska, I. J., Hughes, B., Arlt, W., Stewart, P. M., & Ride, J. P.
- Affiliations
- School of Biosciences and
- University of Birmingham (GB)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2011-02-15
- Volume
- 108
- Issue
- 10
- Pages
- 4111-4116
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3054023
- OpenAlex
- W1982600255
- Cited by
- 61
- References
- 35
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 6 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 7 · 2017: 3 · 2016: 2 · 2015: 1 · 2014: 7 · 2013: 7 · 2012: 8
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Wellcome Trust (066357, 074088)
- National Institute for Health and Care Research (NF-SI-0508-10356)
- Biotechnology and Biological Sciences Research Council (BB/G023468/1)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, heterozygous mutation, dominant negative effect, salt bridges, subunit interface, active site residues, cortisol clearance, hyperandrogenism, glucocorticoid metabolism
- MeSH terms
- Amino Acid Sequence, Animals, Cell Line, Female, Heterozygote, Hirsutism, Humans, Hydrocortisone, Male, Molecular Sequence Data, Mutation, Pedigree, Sequence Homology, Amino Acid, Dimerization, Catalytic Domain, 11-beta-Hydroxysteroid Dehydrogenases, Steroid Metabolism, Inborn Errors, 11-beta-Hydroxysteroid Dehydrogenase Type 1, 46, XX Disorders of Sex Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cortisone-reductase deficiency associated with heterozygous mutations in 11β-hydroxysteroid dehydrogenase type 1. https://app.cochat.ai/papers/10.1073/pnas.1014934108
- The paper
- Lawson, A. J., Walker, E. A., Lavery, G. G., Bujalska, I. J., Hughes, B., Arlt, W., Stewart, P. M., & Ride, J. P. (2011). Cortisone-reductase deficiency associated with heterozygous mutations in 11β-hydroxysteroid dehydrogenase type 1. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1014934108
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.